Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Compass Therapeutics Inc (CMPX)

198 + Investors. Track Smart Money conviction in CMPX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +30
Streak
3Q ▲
Buyers last Q
63%

Smart Money Signals — CMPX

Based on 199 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added CMPX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
199 hedge funds hold CMPX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +69% more funds vs a year ago

fund count last 6Q
+81 new funds entered over the past year (+69% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 63% buying

125 buying74 selling
Last quarter: 125 funds were net buyers (54 opened a brand new position + 71 added to an existing one). Only 74 were sellers (50 trimmed + 24 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~54 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 17 → 31 → 58 → 54. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 48% entered in last year

■ 24% conviction (2yr+) ■ 29% medium ■ 48% new
Only 47 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
🚀

Acceleration phase — new buyers rushing in

39 → 17 → 31 → 58 → 54 new funds/Q
New funds entering each quarter: 17 → 31 → 58 → 54. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 36% veterans, 52% new entrants

■ 36% veterans ■ 12% 1-2yr ■ 52% new
Of 206 current holders: 75 (36%) held 2+ years, 24 held 1–2 years, 107 (52%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
44 of 196 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.4
out of 10
Moderate Exit Risk
Exit risk score 5.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CMPX

In 2026 Q1, 125 hedge funds were net buyers of CMPX (54 opened a new position, 71 added to an existing one), while 74 reduced or exited (50 trimmed, 24 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 22% of total institutional value in CMPX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +30 funds (more new holders than closures). Total institutional holders: 199.

Hedge Fund Ownership: CMPX

How many hedge funds hold CMPX — quarterly history vs. share price
Quarterly hedge fund ownership of CMPX vs. share price

Market Analysis: CMPX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CMPX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Compass Therapeutics Inc (CMPX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CMPX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 46d ago
CMPX
+2.7%
XLV
+5.5%

CMPX outperformed XLV by -2.8% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 1d ago
CMPX
+0.0%
XLV
+0.0%

Since the filing became public, CMPX outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 3 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
2.9
/ 10
conviction
Hedge Fund Positioning: CMPX
2026 Q2 Stats Unlock in 4 days 198 + Investors

Track Smart Money conviction in CMPX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 198 169 17.16%
13F Shares 176M 165M 6.88%
Total Value $934M $940M -0.62%
New Positions 53 58 -5
Increased Positions 72 59 +13
Closed Positions 24 12 +12
Reduced Positions 47 33 +14
Total Calls 6 0 100%
Total Puts 3 0 100%
PUT/CALL Ratio 0.5 0.0 Bullish

Statistics: CMPX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

198 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CMPX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 CMPX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Enavate Sciences GP, LLC 4.94% 7,788,150 $17.1M
2 Tang Capital Management LLC 1.79% 17,990,782 $39.4M
3 Birchview Capital, LP 1.72% 1,675,000 $3.7M
4 Vivo Capital, LLC 1.55% 7,757,060 $17.0M
5 KVP Capital Advisors, LP 1.24% 771,000 $1.7M
6 Blue Owl Capital Holdings LP 1.19% 3,624,076 $7.9M
7 Acuta Capital Partners, LLC 0.91% 595,213 $1.3M
8 CM Management, LLC 0.77% 550,000 $1.2M
9 Atle Fund Management AB 0.62% 1,048,593 $2.3M
10 Orbimed Advisors LLC 0.62% 15,219,994 $33.3M
11 Montanova Capital, LLC 0.56% 14,101,159 $30.9M
12 Rock Springs Capital Management LP 0.38% 3,524,929 $7.7M
13 Exome Asset Management LLC 0.37% 276,165 $605K
14 Kingdon Capital Management, L.L.C. 0.31% 1,400,000 $3.1M
15 Artia Global Partners LP 0.15% 383,200 $839K
16 Virtus Investment Advisers, LLC 0.08% 161,181 $353K
17 nVerses Capital, LLC 0.08% 23,330 $51K
18 Dv Equities, LLC 0.07% 233,066 $510K
19 SmartHarvest Portfolios, LLC 0.06% 86,508 $189K
20 Burkehill Global Management, LP 0.06% 700,000 $1.5M
21 Sound Capital Solutions LLC 0.04% 80,160 $176K
22 ArrowMark Colorado Holdings LLC 0.03% 364,742 $799K
23 Royce & Associates LP 0.02% 1,336,780 $2.9M
24 Wealthcare Capital Partners, LLC 0.02% 19,654 $43K
25 ACT Advisors, LLC. 0.02% 20,613 $45K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Compass Therapeutics Inc (CMPX)

What does the Smart Money Trend signal show for CMPX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added CMPX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CMPX?

More buyers than sellers — 63% buying: Last quarter: 125 funds were net buyers (54 opened a brand new position + 71 added to an existing one). Only 74 were sellers (50 trimmed + 24 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CMPX holders?

Strong quality — 22% AUM from major funds: 44 of 196 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CMPX?

Mostly new holders — 48% entered in last year: Only 47 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Compass Therapeutics Inc (CMPX) following the 2026 Q2 hedge fund 13F filings?

As of today, CMPX has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), CMPX has gained +2.7% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →